Lecture 32 - Cardiovascular Therapeutics Flashcards

1
Q

What is the function of the cardiovascular system?

A

o Distribution of essential substances
o Removal of metabolic by-products
o Circulation of hormones and neurotransmitters
o Heat distribution
o Mediation of inflammatory and host defence responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pulmonary circulation

A

Right atrium and ventricle pumps deoxygenation blood to lungs for O2/CO2 exchange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

systemic circulation

A

Left atrium and ventricle pumps blood to tissues of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

blood vessels

A

o Distributing tubes = arteries/arterioles
o Exchange tubes = capillaries
o Collecting tubes = veins/venules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how is blood pressure controlled?

A

Short-term regulation via neural reflex’s
- Moment to moment regulations
- Seconds to minutes
- Effectors are the heart, vessels an adrenal medulla
Long-term regulation
- Involves changes in extracellular fluid
- Targets blood vessels and kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

baroreceptors

A

o Detect changes in blood pressure
o Located at high pressure sites
o Increased stretch = activation of baroreceptors = increased firing of afferent sensory nerves which transmit information to the cardiovascular control centre.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

blood pressure is a function of:

A

TPR and CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

cardiac output (CO) is a function of:

A

stroke volume (SV) and heart rate (HR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

stroke volume involves:

A

o Preload (load placed on cardiac muscle before contraction)
o Contractility (strength of contraction – intrinsic to cardiac muscle fibres

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

heart rate is controlled by:

A

o Positive feedback of sympathetic activity
o Negative feedback of parasympathetic activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how does preload influence SV?

A

o Depends on ventricular filled and thus venous inflow
o Increased venous flow = increased ventricular filling = increased cardiac muscle fibre length
o Thus greater force generated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why should we treat hypertension?

A

o Elevated BP can cause pathological changes in vascular and hypertrophy of left ventricle
o Leading cause of stoke, coronary artery disease, MI and sudden death, heart failure, renal insufficiency and more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

hypertension causes

A

Primary/essential hypertension (90-95%)
 No apparent cause
 Diet, obesity, high alcohol consumption, physical inactivity

Secondary essential hypertension (5-10%)
 Identifiable cause
 Renal disease
 Endocrine disorders
 Preeclampsia in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hypertension treatment

A

o First choice therapy = lifestyle modifications (i.e. increase exercise, decrease alcohol, better diet)
o Drugs (long-term) but all have some adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how to lower CO

A

o Decrease heart rate and contractility
o Decrease blood volume and therefore preload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

B-adrenoceptor antagonists mechanism of action

A

o Bind but do not activate B-adrenoceptors, thus inhibit activation of cardiac B1-adrenoceptors by noradrenaline and ciruclarion adrenaline
o Bind to and inhibit activation of kidney B1-adrenoceptors

17
Q

adverse effects of B-adrenoceptor antagonists

A

o Decreases exercise capacity
o Muscle fatigue
o Cold extremities
o Bronchoconstriction
o Dreams and insomnia

18
Q

How to minimise adverse effects of b-adrenoceptor antagonists

A

Use B1-selective antagonists (cardio selective) that are more hydrophilic

19
Q

determinants of resistance

A

o Vessel length (constant)
o Blood viscosity (relatively constant)
o Vessel diameter i.e. radius (easily changed)

20
Q

what happens if internal radius falls by 10%

A

o Smaller arteries and arterioles gave a greater capacity to affect TPR than larger arteries
o Decreasing radius increases blood flow but large amount

21
Q

Regulators of arterial tone – passive factors

A

o Pressure
o Architecture/structure of blood vessels

22
Q

Regulators of arterial tone – active factors

A

o Sympathetic nerves
o Circulating factors e.g. catecholamines
o Local vasoactive factors e.g. released from endothelial cells

23
Q

why is TPR elevated during hypertension?

A

o Due to functional imbalance between constriction and relaxation and structural changes
o As blood pressure rises, blood vessels undergo structural changes (remodelling)

24
Q

consequences of vascular remodelling

A

o Resting vascular resistance is raised
o For a given constrictor stimulus, there is a greater increase in R and thus BP

25
how can we lower TPR?
o By inhibiting sympathetic activation of blood vessels o By inhibiting the renin-angiotensin system o By inhibiting signalling pathways involved in smooth muscle contraction
26
a1=adrenoceptor antagonists’ mechanisms of action
o Bind to and inhibit vascular a1-adrenoceptors o Inhibit noradrenaline-mediated vasoconstriction (inhibit sympathetic vascular tone) o Decrease TPR o Decrease BP
27
a1-adrenoceptor antagonist side effects
o 1st dose hypotension o Nasal congestion o Postural hypotension o Initial reflex tachycardia
28
Renin-angiotensin-aldosterone system
Altering levels of enzymes in this system has implications for BP
29
RAAS inhibitors mechanisms of action
both orally available same adverse effects as ACE inhibitors except for dry cough
30
ACE inhibitors mechanism of action
o Less angiotensin II formation o Inhibit bradykinin breakdown thus more vasodilation, lower TPR and BP o Long term mechanism  May in inhibit or decrease morbid influences of angiotensin II on cardiovascular structure, independently of BP lowering effects
31
RAAS inhibitors adverse effects
o 1st dose hypotension o Hyperkalaemia (increase in K+) o Acute renal failure (reversible) o Dry cough
32
RAAS inhibitors advantages
o Less effect on cardiovascular reflexes o Safe in asthmatics o Beneficial effects on cardiovascular remodelling